Clinical Trial

Effect of Gut Microbiota and Its Metabolites on the Efficacy of Immunotherapy in Metastatic Colorectal Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 4, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this observational study is to understand the effect of gut microbiota on the efficacy of immunotherapy in patients with metastatic colorectal cancer and to explore the specific mechanisms of this process. In this way, it provides new ideas for the clinical treatment of colorectal cancer.
Trial Details
NCT Number NCT06714903
Lead Sponsor The First Hospital of Jilin University
Conditions Colorectal Neoplasms Malignant
Enrollment 50 participants
Start Date 2024-07-15
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-04